SymBio Pharmaceuticals LimitedTSE 4582
シンバイオ製薬株式会社 · Pharmaceutical · FY ends Dec
Share price at FY-end
—
FY ending Dec 2025
Avg. director pay
¥69.3M
Internal directors
Top 10 shareholders
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|
| 1 |
吉田 文紀
|
1,684,200 |
2.83% |
— |
— |
| 2 |
楽天証券株式会社共有口
|
1,414,000 |
2.38% |
— |
— |
| 3 |
株式会社SBI証券
|
1,384,480 |
2.33% |
— |
— |
| 4 |
MORGAN STANLEY & CO. LLC
|
951,028 |
1.60% |
— |
— |
| 5 |
JPモルガン証券株式会社
|
542,472 |
0.91% |
— |
— |
| 6 |
STATE STREET BANK AND TRUST COMPANY 510643
|
512,000 |
0.86% |
— |
— |
| 7 |
陳元
|
466,800 |
0.78% |
— |
— |
| 8 |
村山 信也
|
402,200 |
0.68% |
— |
— |
| 9 |
木下 みどり
|
336,000 |
0.56% |
— |
— |
| 10 |
日本証券金融株式会社
|
313,900 |
0.53% |
— |
— |
Officers' holdings and pay
| Name | Title | Shares | Value | Pay |
|---|
| 吉田 文紀 |
President, Representative Director & Executive Officer, CEO |
1,684,200 |
— |
— |
| 野村 博 |
Director |
— |
— |
— |
| ブルース・デビッド・ チェソン |
Director |
— |
— |
— |
| ジョージ・モースティン |
Director |
— |
— |
— |
| ラルフ・スモーリング |
Director |
— |
— |
— |
| 下村 恒一 |
Director |
— |
— |
— |
| 水谷 英滋 |
Director |
700 |
— |
— |
| 市野澤 剛士 |
Director |
— |
— |
— |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
Per-share data by fiscal year
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|
| FY ending Dec 2025 |
— |
¥-95.12 |
— |
— |
59,567,080 |
| FY ending Dec 2024 |
¥643 |
¥-85.00 |
— |
— |
45,928,856 |
| FY ending Dec 2023 |
¥643 |
¥-49.19 |
— |
— |
42,278,081 |
| FY ending Dec 2022 |
¥643 |
¥30.20 |
21.3x |
— |
39,603,606 |
| FY ending Dec 2021 |
¥1,146 |
¥53.04 |
21.6x |
— |
38,457,206 |
| FY ending Dec 2020 |
¥1,146 |
¥-124.13 |
— |
— |
38,202,956 |
| FY ending Dec 2019 |
¥1,146 |
¥-189.03 |
— |
— |
26,437,681 |
| FY ending Dec 2018 |
— |
¥-41.38 |
— |
— |
82,398,924 |
| FY ending Dec 2017 |
— |
¥-79.78 |
— |
— |
54,049,224 |
| FY ending Dec 2016 |
— |
¥-58.82 |
— |
— |
46,530,824 |
Source: annual securities reports on EDINET. Values are estimates.
Methodology